|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2 Suppl 65
|
|
pubmed:dateCreated |
2011-5-18
|
|
pubmed:abstractText |
Systemic sclerosis (SSc) is associated with a marked economic burden, high treatment costs and decreased productivity. Although treatment strategies for SSc can have a substantial effect on patients' outcomes, it is not known whether patients with SSc consistently receive such care. Evaluation of process-of-care quality requires specification of quality indicators (QIs), clinically detailed statements of the eligible patients and the care they should receive to achieve a minimal level of quality of care. Our objective was to develop QIs for patients with SSc.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-856X
|
|
pubmed:author |
pubmed-author:AschSteven MSM,
pubmed-author:BrownKevin KKK,
pubmed-author:ClementsPhilip JPJ,
pubmed-author:FurstDaniel EDE,
pubmed-author:GetzugTerryT,
pubmed-author:KhannaDineshD,
pubmed-author:KhannaPuja PPP,
pubmed-author:Kowal-BieleckaOtyliaO,
pubmed-author:LapinskaAnnaA,
pubmed-author:MaranianPaulP,
pubmed-author:MayesMaureen DMD,
pubmed-author:MedsgerThomas ATA,
pubmed-author:OudizRonaldR,
pubmed-author:SimmsRobertR,
pubmed-author:SteenVirginiaV,
pubmed-author:WengerNeilN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
S33-9
|
|
pubmed:meshHeading |
|
|
pubmed:articleTitle |
Quality indicator set for systemic sclerosis.
|
|
pubmed:affiliation |
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, USA. dkhanna@mednet.ucla.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
